4-Amino-2-chloropyridine

We are 4-Amino-2-chloropyridine CAS:14432-12-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 14432-12-3
Product Name: 4-Amino-2-chloropyridine
Other Name:
4-Amino-2-chloropyridine
2-Chloro-4-aminopyridine
2-chloropyridin-4-amine
2-Chloro-4-pyridinamine
 
Density: 1.3±0.1 g/cm3
Boiling Point: 299.9±20.0 °C at 760 mmHg
Melting Point: 90-94 °C(lit.)
Molecular Formula: C5H5ClN2
Molecular Weight: 128.560
Flash Point: 135.2±21.8 °C
Exact Mass: 128.014130
PSA: 38.91000
LogP: 1.21
Vapour Pressure: 0.0±0.6 mmHg at 25°C
Index of Refraction: 1.607
 
Specification
Appearance: Colorless to yellowish crystal
Assay: ≥99.0%
Water: ≤0.5%
2-Aminopyridine: ≤0.2%
3-Aminopyridine: ≤0.2%
Sulphated ash: ≤0.2%
 
Application
Intermediates of Forchlorfenuron CAS: 68157-60-8.
Be used as pesticide intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

4-Amino-2-chloropyridine


Related News: At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves.7-Chlorohept-1-ene On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.N-Boc-L-phenylalaninal On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.3-Chloropivalic Acid Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).

Related Products
Product Name
4-Amino-5-(ethylsulfonyl)-2-methoxybenzoic acid View Details
5-nitro-o-toluidine View Details
2,3-Dichloro-5-nitropyridine View Details
(R)-Methyl 2-amino-2-(4-hydroxyphenyl)acetate manufacturer N-[[(1,1-Dimethylethyl)Amino]Carbonyl]-3-Methyl-L-Valine manufacturer 1-[2-Chloro-4-(4-chlorophenoxy)phenyl]ethan-1-one manufacturer 5-aza-2′-deoxycytidine manufacturer 1,3-Dibromo-5-fluorobenzene manufacturer